MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)

Phase 2

Completed

• Conditions: Seasonal Allergies

• Registration Number: NCT00533208
• Lead Sponsor: Merck Sharp & Dohme LLC

Brief Summary

To assess the efficacy of MK0524 on seasonal allergies.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design

Study Timeline

• Study Start: 2003-07
• Primary Completion: 2003-10
• Study Completion: 2003-10
• Study First Submitted: 2007-09-19
• Study First Submitted QC: 2007-09-19
• Study First Posted: 2007-09-21
• Status Verified: 2015-12
• Last Update Submitted: 2015-12-21
• Last Update Posted: 2015-12-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 766

Inclusion Criteria

• Person has had at least 2 years of seasonal allergies
• Person has had a positive skin test to at least 1 of the allergens of the season
• Person is a non-smoker

Read More

Exclusion Criteria

• Person has been hospitalized within the last 4 weeks
• Person is a female who has had a baby within the last 8 weeks or is still breast-feeding

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL